Page

Name

E-mail

Message

2025-10-30

#reports #WEX

[WEX](https://eninvs.com/all.php?name=WEX) (Payment processing service provider) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +3.9% YoY (vs -2.1% in previous quarter and historical rate +6.0%)
- EBITDA -3.5% YoY (vs -3.0% in previous quarter and historical rate +25.7%)
- EBITDA margin 32.2% decreased compared to 34.7% same period last year
- Net Debt decreased by $443 mln over the past reporting period (6.6% of market cap)
- FCF (LTM) +$0.6 bln (positive), 8.7% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 2.6x

------------------------------------------------

2025-10-30

#reports #VRSK

[Verisk Analytics](https://eninvs.com/all.php?name=VRSK) (Analytical service provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192498)
(2025-10-29, Before Market Open):

- Revenue +5.9% YoY (vs +7.8% in previous quarter and historical rate +0.5%)
- EBITDA +7.9% YoY (vs +7.9% in previous quarter and historical rate +4.8%)
- EBITDA margin 60.7% increased compared to 59.6% same period last year
- Net Debt decreased by $18 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 18.5x compared to historical level (75th percentile) of 23.4x
- EV/Sales multiple is 10.5x

At the opening of the session the share price went down -10.2% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #VRRM

[Verra Mobility](https://eninvs.com/all.php?name=VRRM) (Security and Protection Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192497)
(2025-10-29, After Market Close):

- Revenue +15.9% YoY (vs +6.3% in previous quarter and historical rate +9.2%)
- EBITDA +13.2% YoY (vs +3.4% in previous quarter and historical rate -8.1%)
- EBITDA margin 39.3% decreased compared to 40.3% same period last year
- Net Debt decreased by $34 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 17.7x compared to historical level (75th percentile) of 18.2x
- EV/Sales multiple is 4.9x

------------------------------------------------

2025-10-30

#reports #VNDA

[Vanda Pharmaceuticals](https://eninvs.com/all.php?name=VNDA) (Small molecule drugs developer) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +16.7% YoY (vs +6.0% in previous quarter and historical rate -3.8%)
- EBITDA margin -55.4% decreased compared to -22.9% same period last year
- Net Debt increased by $31 mln over the past reporting period (9.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 16.3% of market cap
- EV/Sales multiple is 0.1x

------------------------------------------------

2025-10-30

#reports #UDMY

[Udemy, Inc.](https://eninvs.com/all.php?name=UDMY) (Education and Training Services) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +0.5% YoY (vs +3.1% in previous quarter and historical rate +10.1%)
- EBITDA margin 11.7% increased compared to -4.1% same period last year
- Net Debt increased by $24 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) +$0 bln (positive), 4.3% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 43.2x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-10-30

#reports #TYL

[Tyler Technologies](https://eninvs.com/all.php?name=TYL) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192495)
(2025-10-29, After Market Close):

- Revenue +9.8% YoY (vs +10.2% in previous quarter and historical rate +7.9%)
- EBITDA -9.5% YoY (vs +56.6% in previous quarter and historical rate +13.6%)
- EBITDA margin 22.3% decreased compared to 27.1% same period last year
- Net Debt decreased by $56 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 41.2x compared to historical level (75th percentile) of 55.6x
- EV/Sales multiple is 8.8x

------------------------------------------------

2025-10-30

#reports #TTMI

[TTM Technologies](https://eninvs.com/all.php?name=TTMI) (Printed circuit board manufacturer) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +22% YoY (vs +20.8% in previous quarter and historical rate +4.7%)
- EBITDA +25% YoY (vs +40.4% in previous quarter and historical rate +23.5%)
- EBITDA margin 13.9% increased compared to 13.6% same period last year
- Net Debt decreased by $43 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 20.5x compared to historical level (75th percentile) of 11.7x
- EV/Sales multiple is 2.5x

------------------------------------------------

2025-10-30

#reports #TMDX

[TransMedics Group](https://eninvs.com/all.php?name=TMDX) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192493)
(2025-10-29, After Market Close):

- Revenue +32.1% YoY (vs +37.7% in previous quarter and historical rate +109.1%)
- EBITDA +100% YoY (vs +230.8% in previous quarter and historical rate +125.0%)
- EBITDA margin 20.8% increased compared to 13.8% same period last year
- Net Debt decreased by $65 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 37.2x compared to historical level (75th percentile) of 64.7x
- EV/Sales multiple is 8.1x

------------------------------------------------

2025-10-30

#reports #TKR

[The Timken Company](https://eninvs.com/all.php?name=TKR) (Power transmission products manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192492)
(2025-10-29, Before Market Open):

- Revenue +2.7% YoY (vs -0.8% in previous quarter and historical rate +1.1%)
- EBITDA -2% YoY (vs -7.2% in previous quarter and historical rate +4.7%)
- EBITDA margin 17.1% decreased compared to 17.9% same period last year
- Net Debt decreased by $123 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 9.6x
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +7.5% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #TDOC

[Teladoc Health](https://eninvs.com/all.php?name=TDOC) (Health care provider) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue -2.3% YoY (vs -1.6% in previous quarter and historical rate +3.1%)
- EBITDA margin -7.8% decreased compared to -6.6% same period last year
- Net Debt decreased by $40 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-10-30

#reports #SNCY

[Sun Country Airlines Holdings, Inc.](https://eninvs.com/all.php?name=SNCY) (Airlines) reported for 2025 q3
(2025-10-29, Before Market Open):

- Revenue +2.8% YoY (vs +3.9% in previous quarter and historical rate +27.5%)
- EBITDA -2.8% YoY (vs +13.9% in previous quarter and historical rate +51.8%)
- EBITDA margin 13.7% decreased compared to 14.5% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.2% of market cap)
- EV/EBITDA multiple is 1.8x compared to historical level (75th percentile) of 4.6x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +0.1% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #SCL

[Stepan Company](https://eninvs.com/all.php?name=SCL) (Specialty and intermediate chemicals manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SCL&q=2025 q3&id=892401)
(2025-10-29, Before Market Open):

- Revenue +7.9% YoY (vs +7.0% in previous quarter and historical rate -7.6%)
- EBITDA -9.5% YoY (vs -3.2% in previous quarter and historical rate +1.5%)
- EBITDA margin 11.4% decreased compared to 13.5% same period last year
- Net Debt decreased by $26 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 21.2% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 19.7x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -1.0% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #SCI

[Service Corporation International](https://eninvs.com/all.php?name=SCI) (Funeral service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SCI&q=2025 q3&id=892400)
(2025-10-29, After Market Close):

- Revenue +4.3% YoY (vs +3.0% in previous quarter and historical rate +1.4%)
- EBITDA +6.1% YoY (vs +2.6% in previous quarter and historical rate +29.8%)
- EBITDA margin 29.6% increased compared to 29.1% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 13x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 4x

------------------------------------------------

2025-10-30

#reports #PI

[Impinj](https://eninvs.com/all.php?name=PI) (Communication Equipment) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192485)
(2025-10-29, After Market Close):

- Revenue +1.1% YoY (vs -3.9% in previous quarter and historical rate +18.0%)
- EBITDA +150% YoY (vs +25.0% in previous quarter and historical rate +47.9%)
- EBITDA margin 5.2% increased compared to 2.1% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 711.4x compared to historical level (75th percentile) of 1345.5x
- EV/Sales multiple is 19.8x

------------------------------------------------

2025-10-30

#reports #PAG

[Penske Automotive Group](https://eninvs.com/all.php?name=PAG) (Transportation services provider) reported for 2025 q3
(2025-10-29, Before Market Open):

- Revenue +1.4% YoY (vs -0.5% in previous quarter and historical rate +4.3%)
- EBITDA -4.5% YoY (vs +3.4% in previous quarter and historical rate -4.1%)
- EBITDA margin 4.4% decreased compared to 4.7% same period last year
- Net Debt decreased by $410 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 13.7x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -5.0% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #OTIS

[Otis Worldwide](https://eninvs.com/all.php?name=OTIS) (Elevator manufacturer) reported for 2025 q3
(2025-10-29, Before Market Open):

- Revenue +4% YoY (vs -0.2% in previous quarter and historical rate +1.2%)
- EBITDA +53.3% YoY (vs -3.3% in previous quarter and historical rate +6.2%)
- EBITDA margin 17.1% increased compared to 11.6% same period last year
- Net Debt increased by $185 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 20.7x compared to historical level (75th percentile) of 21.3x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +3.0% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #OSK

[Oshkosh Corporation](https://eninvs.com/all.php?name=OSK) (Vehicle manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192484)
(2025-10-29, Before Market Open):

- Revenue -1.9% YoY (vs -4.0% in previous quarter and historical rate +10.0%)
- EBITDA -0.3% YoY (vs +12.6% in previous quarter and historical rate +72.1%)
- EBITDA margin 11.8% increased compared to 11.6% same period last year
- Net Debt decreased by $312 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 9.1x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went down -4.4% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #OPK

[OPKO Health](https://eninvs.com/all.php?name=OPK) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192483)
(2025-10-29, After Market Close):

- Revenue -12.6% YoY (vs -13.7% in previous quarter and historical rate -16.5%)
- EBITDA +82.9% YoY (vs -3400.0% in previous quarter and historical rate +14.3%)
- EBITDA margin 49.3% increased compared to 23.6% same period last year
- Net Debt decreased by $141 mln over the past reporting period (12.5% of market cap)
- FCF (LTM) +$0.5 bln (positive), 40.6% of market cap
- EV/Sales multiple is 1.6x

------------------------------------------------

2025-10-30

#reports #MUSA

[Murphy USA](https://eninvs.com/all.php?name=MUSA) (Motor fuel supplier) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=MUSA&q=2025 q3&id=892366)
(2025-10-29, After Market Close):

- Revenue -2.5% YoY (vs -8.2% in previous quarter and historical rate -4.9%)
- EBITDA -4.2% YoY (vs +3.3% in previous quarter and historical rate -3.2%)
- EBITDA margin 5.3% has not changed compared to 5.4% same period last year
- Net Debt increased by $175 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0.3 bln (negative), 3.5% of market cap
- EV/EBITDA multiple is 10.6x compared to historical level (75th percentile) of 11.9x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-10-30

#reports #MGPI

[MGP Ingredients](https://eninvs.com/all.php?name=MGPI) (Liquor manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192476)
(2025-10-29, Before Market Open):

- Revenue -18.6% YoY (vs -24.1% in previous quarter and historical rate -7.7%)
- EBITDA -28.6% YoY (vs -50.0% in previous quarter and historical rate -30.3%)
- EBITDA margin 19.1% decreased compared to 21.7% same period last year
- Net Debt decreased by $25 mln over the past reporting period (4.7% of market cap)
- FCF (LTM) -$0 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 23.3x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +8.6% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #MDXG

[MiMedx Group](https://eninvs.com/all.php?name=MDXG) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192474)
(2025-10-29, After Market Close):

- Revenue +35.7% YoY (vs +13.8% in previous quarter and historical rate +14.9%)
- EBITDA +100% YoY (vs -68.8% in previous quarter and historical rate +77.0%)
- EBITDA margin 19.3% increased compared to 13.1% same period last year
- Net Debt decreased by $24 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0 bln (positive), 2.8% of market cap
- EV/EBITDA multiple is 21.3x compared to historical level (75th percentile) of 28.4x
- EV/Sales multiple is 2.4x

------------------------------------------------

2025-10-30

#reports #MAS

[Masco](https://eninvs.com/all.php?name=MAS) (Building products manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192472)
(2025-10-29, Before Market Open):

- Revenue -3.3% YoY (vs -1.9% in previous quarter and historical rate -9.2%)
- EBITDA -13.9% YoY (vs +3.8% in previous quarter and historical rate -6.1%)
- EBITDA margin 17.4% decreased compared to 19.6% same period last year
- Net Debt decreased by $220 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0.3 bln (negative), 2.0% of market cap
- EV/EBITDA multiple is 15.9x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went down -5.7% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #KHC

[Kraft Heinz Co](https://eninvs.com/all.php?name=KHC) (Food products provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192470)
(2025-10-29, Before Market Open):

- Revenue -2.3% YoY (vs -1.9% in previous quarter and historical rate -0.7%)
- EBITDA +794.4% YoY (vs -1117.5% in previous quarter and historical rate +11.0%)
- EBITDA margin 20.4% increased compared to 2.2% same period last year
- Net Debt decreased by $592 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.3% of market cap
- EV/Sales multiple is 1.9x

At the opening of the session the share price went down -2.0% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #JBSS

[John B Sanfilippo & Son](https://eninvs.com/all.php?name=JBSS) (Snack manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192468)
(2025-08-20, After Market Close):

- Revenue +8.3% YoY (vs -0.4% in previous quarter and historical rate +5.1%)
- EBITDA +41.7% YoY (vs +12.5% in previous quarter and historical rate +11.0%)
- EBITDA margin 11.4% increased compared to 8.7% same period last year
- Net Debt increased by $9 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 6.1x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -3.1% vs S&P500 -0.2%

------------------------------------------------

2025-10-30

#reports #IONS

[Ionis Pharmaceuticals](https://eninvs.com/all.php?name=IONS) (Drug Developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192466)
(2025-10-29, Before Market Open):

- Revenue +17.2% YoY (vs +100.9% in previous quarter and historical rate +22.6%)
- EBITDA margin -96.2% increased compared to -103.7% same period last year
- Net Debt increased by $151 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0.8 bln (negative), 7.6% of market cap
- EV/Sales multiple is 10.4x

At the opening of the session the share price went down -1.6% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #HAYW

[Hayward Holdings, Inc.](https://eninvs.com/all.php?name=HAYW) (Electrical Equipment and Parts) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192463)
(2025-10-29, Before Market Open):

- Revenue +7% YoY (vs +5.6% in previous quarter and historical rate -5.3%)
- EBITDA +23.4% YoY (vs +7.8% in previous quarter and historical rate -2.4%)
- EBITDA margin 23.8% increased compared to 20.6% same period last year
- Net Debt decreased by $84 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 5.0% of market cap
- EV/EBITDA multiple is 15.2x compared to historical level (75th percentile) of 17.7x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went up +10.9% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #GTLS

[Chart Industries](https://eninvs.com/all.php?name=GTLS) (Industrial equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192462)
(2025-10-29, Before Market Open):

- Revenue +3.6% YoY (vs +4.0% in previous quarter and historical rate +54.5%)
- EBITDA -106.9% YoY (vs +3.0% in previous quarter and historical rate +68.8%)
- EBITDA margin -1.5% decreased compared to 23.2% same period last year
- Net Debt decreased by $110 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 15.4x compared to historical level (75th percentile) of 20.1x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -0.1% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #GRMN

[Garmin](https://eninvs.com/all.php?name=GRMN) (Navigation devices manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192460)
(2025-10-29, Before Market Open):

- Revenue +11.7% YoY (vs +20.4% in previous quarter and historical rate +12.4%)
- EBITDA +5% YoY (vs +34.5% in previous quarter and historical rate +18.4%)
- EBITDA margin 28.6% decreased compared to 30.4% same period last year
- Net Debt increased by $55 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 20.3x compared to historical level (75th percentile) of 22.3x
- EV/Sales multiple is 5.7x

At the opening of the session the share price went down -11.1% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #GKOS

[Glaukos Corporation](https://eninvs.com/all.php?name=GKOS) (Medicine services provider) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +38.1% YoY (vs +29.2% in previous quarter and historical rate +18.4%)
- EBITDA margin -14.9% increased compared to -28.9% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.5% of market cap
- EV/Sales multiple is 9x

------------------------------------------------

2025-10-30

#reports #GH

[Guardant Health](https://eninvs.com/all.php?name=GH) (Medicine services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192458)
(2025-10-29, After Market Close):

- Revenue +38.7% YoY (vs +31.1% in previous quarter and historical rate +28.0%)
- EBITDA margin -35.1% increased compared to -58.1% same period last year
- Net Debt increased by $41 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.7% of market cap
- EV/Sales multiple is 9x

------------------------------------------------

2025-10-30

#reports #FTV

[Fortive](https://eninvs.com/all.php?name=FTV) (Industrial services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192456)
(2025-10-29, Before Market Open):

- Revenue -33.1% YoY (vs -2.1% in previous quarter and historical rate 0.0%)
- EBITDA -50.6% YoY (vs -17.8% in previous quarter and historical rate +2.2%)
- EBITDA margin 20.7% decreased compared to 28.1% same period last year
- Net Debt decreased by $104 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 15.1x compared to historical level (75th percentile) of 18.8x
- EV/Sales multiple is 3.7x

At the opening of the session the share price went up +11.7% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #FORM

[FormFactor](https://eninvs.com/all.php?name=FORM) (Probe board manufacturer) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue -2.4% YoY (vs -0.5% in previous quarter and historical rate -0.2%)
- EBITDA 0% YoY (vs -15.4% in previous quarter and historical rate +30.9%)
- EBITDA margin 12.8% increased compared to 12.5% same period last year
- Net Debt decreased by $20 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 44.8x compared to historical level (75th percentile) of 40.8x
- EV/Sales multiple is 4.5x

------------------------------------------------

2025-10-30

#reports #FMC

[FMC](https://eninvs.com/all.php?name=FMC) (Agricultural chemicals supplier) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=FMC&q=2025 q3&id=892316)
(2025-10-29, After Market Close):

- Revenue -49.1% YoY (vs +1.3% in previous quarter and historical rate -12.5%)
- EBITDA -464.7% YoY (vs +161.5% in previous quarter and historical rate -5.8%)
- EBITDA margin -78.0% decreased compared to 10.9% same period last year
- Net Debt increased by $320 mln over the past reporting period (8.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.0% of market cap
- EV/Sales multiple is 2.1x

------------------------------------------------

2025-10-30

#reports #EXTR

[Extreme Networks](https://eninvs.com/all.php?name=EXTR) (Communication Equipment) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=EXTR&q=2025 q3&id=892310)
(2025-10-29, Before Market Open):

- Revenue +15.2% YoY (vs +19.5% in previous quarter and historical rate +3.9%)
- EBITDA margin 4.8% increased compared to -0.4% same period last year
- Net Debt increased by $41 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 49.8x compared to historical level (75th percentile) of 37.5x
- EV/Sales multiple is 2x

At the opening of the session the share price went down -10.7% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #ETD

[Ethan Allen Interiors](https://eninvs.com/all.php?name=ETD) (Furnishings, Fixtures and Appliances) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192454)
(2025-10-29, After Market Close):

- Revenue -4.5% YoY (vs -5.3% in previous quarter and historical rate -10.3%)
- EBITDA -33.3% YoY (vs -25.9% in previous quarter and historical rate -23.6%)
- EBITDA margin 9.5% decreased compared to 13.6% same period last year
- Net Debt increased by $5 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 4.6% of market cap
- EV/EBITDA multiple is 10.4x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 1.2x

------------------------------------------------

2025-10-30

#reports #EHC

[Encompass Health Corporation](https://eninvs.com/all.php?name=EHC) (Medical services provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=EHC&q=2025 q3&id=892293)
(2025-10-29, After Market Close):

- Revenue +9.4% YoY (vs +12.1% in previous quarter and historical rate +5.2%)
- EBITDA +15.3% YoY (vs +22.4% in previous quarter and historical rate +29.1%)
- EBITDA margin 20.4% increased compared to 19.4% same period last year
- Net Debt increased by $30 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 13.1x compared to historical level (75th percentile) of 14.8x
- EV/Sales multiple is 2.8x

------------------------------------------------

2025-10-30

#reports #EBS

[Emergent BioSolutions](https://eninvs.com/all.php?name=EBS) (Medicines developer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=EBS&q=2025 q3&id=892289)
(2025-10-29, After Market Close):

- Revenue -21.4% YoY (vs -44.7% in previous quarter and historical rate -10.1%)
- EBITDA +53.8% YoY (vs +2400.0% in previous quarter and historical rate +39.1%)
- EBITDA margin 43.3% increased compared to 22.1% same period last year
- Net Debt increased by $17 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 24.6% of market cap
- EV/EBITDA multiple is 3.7x compared to historical level (75th percentile) of 103.8x
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-10-30

#reports #DVA

[DaVita](https://eninvs.com/all.php?name=DVA) (Medical services provider) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +4.8% YoY (vs +6.1% in previous quarter and historical rate +4.6%)
- EBITDA -5.4% YoY (vs +2.8% in previous quarter and historical rate +18.3%)
- EBITDA margin 20.0% decreased compared to 22.1% same period last year
- Net Debt decreased by $45 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$1.1 bln (negative), 8.9% of market cap
- EV/EBITDA multiple is 9x compared to historical level (75th percentile) of 10.8x
- EV/Sales multiple is 1.9x

------------------------------------------------

2025-10-30

#reports #DAN

[Dana](https://eninvs.com/all.php?name=DAN) (Auto Parts) reported for 2025 q3
(2025-10-29, Before Market Open):

- Revenue -45.6% YoY (vs -29.3% in previous quarter and historical rate -5.9%)
- EBITDA -58.9% YoY (vs -57.4% in previous quarter and historical rate +4.2%)
- EBITDA margin 5.8% decreased compared to 7.7% same period last year
- Net Debt increased by $193 mln over the past reporting period (6.2% of market cap)
- FCF (LTM) -$0.3 bln (negative), 10.8% of market cap
- EV/EBITDA multiple is 15.9x compared to historical level (75th percentile) of 8.3x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +3.6% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #CTSH

[Cognizant Technology Solutions](https://eninvs.com/all.php?name=CTSH) (Consulting services provider ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192448)
(2025-10-29, Before Market Open):

- Revenue +7.4% YoY (vs +8.1% in previous quarter and historical rate +2.6%)
- EBITDA +14% YoY (vs +14.4% in previous quarter and historical rate +13.5%)
- EBITDA margin 18.5% increased compared to 17.4% same period last year
- Net Debt decreased by $553 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$1.2 bln (positive), 3.2% of market cap
- EV/EBITDA multiple is 9.4x compared to historical level (75th percentile) of 11.5x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went up +10.9% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #CRTO

[Criteo](https://eninvs.com/all.php?name=CRTO) (Advertising Agencies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192446)
(2025-10-29, Before Market Open):

- Revenue +2.4% YoY (vs +2.5% in previous quarter and historical rate -2.0%)
- EBITDA +193.3% YoY (vs +15.5% in previous quarter and historical rate +47.5%)
- EBITDA margin 18.7% increased compared to 6.5% same period last year
- Net Debt decreased by $54 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 19.0% of market cap
- EV/EBITDA multiple is 2.7x compared to historical level (75th percentile) of 10.8x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +8.7% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #CNXN

[PC Connection](https://eninvs.com/all.php?name=CNXN) (Personal computer supplier) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192443)
(2025-10-29, After Market Close):

- Revenue -2.2% YoY (vs +3.3% in previous quarter and historical rate -8.5%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate -12.1%)
- EBITDA margin 4.7% increased compared to 4.6% same period last year
- Net Debt decreased by $54 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 11.4x compared to historical level (75th percentile) of 12.9x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-10-30

#reports #CMG

[Chipotle Mexican Grill](https://eninvs.com/all.php?name=CMG) (Fast food chain) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=CMG&q=2025 q3&id=892263)
(2025-10-29, After Market Close):

- Revenue +7.5% YoY (vs +3.0% in previous quarter and historical rate +12.0%)
- EBITDA +18.1% YoY (vs -3.0% in previous quarter and historical rate +22.5%)
- EBITDA margin 21.9% increased compared to 20.0% same period last year
- Net Debt increased by $325 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.4 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 23.6x compared to historical level (75th percentile) of 38.7x
- EV/Sales multiple is 4.9x

------------------------------------------------

2025-10-30

#reports #CLH

[Clean Harbors](https://eninvs.com/all.php?name=CLH) (Environmental service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=CLH&q=2025 q3&id=892261)
(2025-10-29, Before Market Open):

- Revenue +1.3% YoY (vs -0.2% in previous quarter and historical rate +6.2%)
- EBITDA +5.5% YoY (vs +3.5% in previous quarter and historical rate +11.1%)
- EBITDA margin 19.9% increased compared to 19.1% same period last year
- Net Debt decreased by $160 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 12.7x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 2.4x

At the opening of the session the share price went down -13.3% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #CHRW

[CH Robinson Worldwide](https://eninvs.com/all.php?name=CHRW) (Logistic company) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=CHRW&q=2025 q3&id=892260)
(2025-10-29, After Market Close):

- Revenue -10.9% YoY (vs -7.7% in previous quarter and historical rate -13.1%)
- EBITDA +21.1% YoY (vs +18.7% in previous quarter and historical rate -5.1%)
- EBITDA margin 6.0% increased compared to 4.4% same period last year
- Net Debt decreased by $170 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.3 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 18.8x compared to historical level (75th percentile) of 20.5x
- EV/Sales multiple is 1x

------------------------------------------------

2025-10-30

#reports #CALX

[Calix](https://eninvs.com/all.php?name=CALX) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=CALX&q=2025 q3&id=892250)
(2025-10-29, After Market Close):

- Revenue +31.8% YoY (vs +22.2% in previous quarter and historical rate +7.9%)
- EBITDA margin 12.5% increased compared to -3.0% same period last year
- Net Debt decreased by $34 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 167.5x compared to historical level (75th percentile) of 59.5x
- EV/Sales multiple is 4x

------------------------------------------------

2025-10-30

#reports #BLCO

[Bausch + Lomb Corporation](https://eninvs.com/all.php?name=BLCO) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192437)
(2025-10-29, Before Market Open):

- Revenue +7.1% YoY (vs +4.9% in previous quarter and historical rate +9.8%)
- EBITDA +82.5% YoY (vs -65.4% in previous quarter and historical rate -17.2%)
- EBITDA margin 9.0% increased compared to 5.3% same period last year
- Net Debt decreased by $50 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0.4 bln (negative), 7.3% of market cap
- EV/EBITDA multiple is 50.5x compared to historical level (75th percentile) of 32.1x
- EV/Sales multiple is 2x

At the opening of the session the share price went up +5.2% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #BIO

[Bio-Rad Laboratories](https://eninvs.com/all.php?name=BIO) ( Products for clinical diagnostics developer) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +0.5% YoY (vs +2.2% in previous quarter and historical rate -3.0%)
- EBITDA +7.8% YoY (vs -14.5% in previous quarter and historical rate +10.2%)
- EBITDA margin 16.8% increased compared to 15.7% same period last year
- Net Debt decreased by $45 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.3 bln (negative), 3.1% of market cap
- EV/EBITDA multiple is 23.9x compared to historical level (75th percentile) of 20.4x
- EV/Sales multiple is 3.6x

------------------------------------------------

2025-10-30

#reports #AXGN

[Axogen](https://eninvs.com/all.php?name=AXGN) (Medical and surgical instruments manufacturer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192433)
(2025-10-29, Before Market Open):

- Revenue +22.4% YoY (vs +18.8% in previous quarter and historical rate +17.1%)
- EBITDA margin 8.3% increased compared to 2.0% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 105.9x compared to historical level (75th percentile) of 255.3x
- EV/Sales multiple is 4.9x

At the opening of the session the share price went up +4.6% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #AWRE

[Aware](https://eninvs.com/all.php?name=AWRE) (Software — Application) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +25% YoY (vs 0.0% in previous quarter and historical rate +8.8%)
- EBITDA margin -20.0% increased compared to -25.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) -$0 bln (negative), 5.5% of market cap
- EV/Sales multiple is 2x

------------------------------------------------

2025-10-30

#reports #AWK

[American Water Works](https://eninvs.com/all.php?name=AWK) (Drinking water supplier) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192432)
(2025-10-29, After Market Close):

- Revenue +9.7% YoY (vs +11.1% in previous quarter and historical rate +10.1%)
- EBITDA +13% YoY (vs +11.0% in previous quarter and historical rate +15.7%)
- EBITDA margin 61.5% increased compared to 59.7% same period last year
- Net Debt increased by $1.1 bln since the start of the year (4.9% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 18.9x compared to historical level (75th percentile) of 22.3x
- EV/Sales multiple is 10.9x

------------------------------------------------

2025-10-30

#reports #AVTR

[Avantor](https://eninvs.com/all.php?name=AVTR) (Chemicals and reagents manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192431)
(2025-10-29, Before Market Open):

- Revenue -5.3% YoY (vs -1.2% in previous quarter and historical rate -4.8%)
- EBITDA -339.6% YoY (vs -16.5% in previous quarter and historical rate +3.5%)
- EBITDA margin -33.5% decreased compared to 13.2% same period last year
- Net Debt decreased by $202 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$1 bln (positive), 13.3% of market cap
- EV/EBITDA multiple is 17x compared to historical level (75th percentile) of 18.9x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went down -17.6% vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #ATRC

[AtriCure](https://eninvs.com/all.php?name=ATRC) (Atrial Fibrillation Device Supplier) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=ATRC&q=2025 q3&id=892234)
(2025-10-29, After Market Close):

- Revenue +15.5% YoY (vs +17.2% in previous quarter and historical rate +18.0%)
- EBITDA margin 3.0% increased compared to -3.4% same period last year
- Net Debt decreased by $33 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/Sales multiple is 3x

------------------------------------------------

2025-10-30

#reports #ALSN

[Allison Transmission](https://eninvs.com/all.php?name=ALSN) ( Fully-automatic transmissions manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=ALSN&q=2025 q3&id=892227)
(2025-10-29, After Market Close):

- Revenue -15.9% YoY (vs -0.2% in previous quarter and historical rate +4.7%)
- EBITDA -18.8% YoY (vs -1.7% in previous quarter and historical rate +38.4%)
- EBITDA margin 33.8% decreased compared to 35.0% same period last year
- Net Debt decreased by $125 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 3x

------------------------------------------------

2025-10-30

#reports #TENB
@ saas

[Tenable](https://eninvs.com/all.php?name=TENB) (Cyber security solution provider) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +11% YoY (vs +11.8% in previous quarter and historical rate +14.7%)
- EBITDA +260% YoY (vs +200.0% in previous quarter and historical rate +66.7%)
- EBITDA margin 7.1% increased compared to 2.2% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 5.3% of market cap
- EV/EBITDA multiple is 108.2x compared to historical level (75th percentile) of 291.5x
- EV/Sales multiple is 3.6x

------------------------------------------------

2025-10-30

#reports #MAA
@ REITs

[Mid-America Apartment](https://eninvs.com/all.php?name=MAA) (Real estate investment trust) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=MAA&q=2025 q3&id=892344)
(2025-10-29, After Market Close):

- Revenue +0.5% YoY (vs +0.7% in previous quarter and historical rate +4.2%)
- EBITDA -2.6% YoY (vs +6.0% in previous quarter and historical rate +7.0%)
- EBITDA margin 46.6% decreased compared to 48.1% same period last year
- Net Debt increased by $169 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 17.2x compared to historical level (75th percentile) of 21x
- EV/Sales multiple is 9.2x

------------------------------------------------

2025-10-30

#reports #INVH
@ REITs

[Invitation Homes](https://eninvs.com/all.php?name=INVH) (Real estate investment fund) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +4.2% YoY (vs +4.3% in previous quarter and historical rate +7.5%)
- EBITDA +3.7% YoY (vs +3.9% in previous quarter and historical rate +32.9%)
- EBITDA margin 81.7% decreased compared to 82.1% same period last year
- Net Debt increased by $505 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) -$0.6 bln (negative), 3.4% of market cap
- EV/EBITDA multiple is 10.6x compared to historical level (75th percentile) of 17.3x
- EV/Sales multiple is 8.7x

------------------------------------------------

2025-10-30

#reports #EPR
@ REITs

[EPR Properties](https://eninvs.com/all.php?name=EPR) (REIT — Retail) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +0.6% YoY (vs +2.9% in previous quarter and historical rate +4.2%)
- EBITDA +2.9% YoY (vs +26.4% in previous quarter and historical rate +5.3%)
- EBITDA margin 76.9% increased compared to 75.1% same period last year
- Net Debt increased by $30 mln over the past reporting period (0.8% of market cap)
- EV/EBITDA multiple is 8.9x compared to historical level (75th percentile) of 9.3x
- EV/Sales multiple is 6.6x

------------------------------------------------

2025-10-30

#reports #EBAY
@ e-commerce

[eBay](https://eninvs.com/all.php?name=EBAY) (Online trade platform ) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +9.5% YoY (vs +6.1% in previous quarter and historical rate +2.7%)
- EBITDA -0.7% YoY (vs -5.6% in previous quarter and historical rate +32.3%)
- EBITDA margin 24.2% decreased compared to 26.7% same period last year
- Net Debt increased by $352 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$2.5 bln (positive), 4.5% of market cap
- EV/EBITDA multiple is 22.9x compared to historical level (75th percentile) of 17.1x
- EV/Sales multiple is 5.5x

------------------------------------------------

2025-10-30

#reports #NOW
@ artificial-intelligence , @ cloud-computing , @ saas

[ServiceNow](https://eninvs.com/all.php?name=NOW) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=NOW&q=2025 q3&id=892373)
(2025-10-29, After Market Close):

- Revenue +21.8% YoY (vs +22.4% in previous quarter and historical rate +37.2%)
- EBITDA +36.8% YoY (vs +49.2% in previous quarter and historical rate +53.8%)
- EBITDA margin 16.8% increased compared to 14.9% same period last year
- Net Debt increased by $714 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.7 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 69.3x compared to historical level (75th percentile) of 174.7x
- EV/Sales multiple is 10.2x

------------------------------------------------

2025-10-30

#reports #UTHR

[United Therapeutics](https://eninvs.com/all.php?name=UTHR) (Medicines manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192427)
(2025-10-29, Before Market Open):

- Revenue +6.8% YoY (vs +11.7% in previous quarter and historical rate +19.2%)
- EBITDA +13.3% YoY (vs +13.9% in previous quarter and historical rate +16.8%)
- EBITDA margin 51.2% increased compared to 48.3% same period last year
- Net Debt increased by $253 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0.4 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 12.3x compared to historical level (75th percentile) of 10.9x
- EV/Sales multiple is 6.2x

At the opening of the session the share price went neutrally vs S&P500 +0.3%

------------------------------------------------

2025-10-30

#reports #NVST

[Envista Corporation](https://eninvs.com/all.php?name=NVST) (Medicines equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=NVST&q=2025 q3&id=893743)
(2025-10-30, After Market Close):

- Revenue +11.5% YoY (vs +7.7% in previous quarter and historical rate +0.9%)
- EBITDA +74% YoY (vs +7500.0% in previous quarter and historical rate +10.2%)
- EBITDA margin 13.0% increased compared to 8.3% same period last year
- Net Debt decreased by $18 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 12.3x compared to historical level (75th percentile) of 19.4x
- EV/Sales multiple is 1.4x

------------------------------------------------

2025-10-29

#reports #ZEUS

[Olympic Steel](https://eninvs.com/all.php?name=ZEUS) (Steel) reported for 2025 q3
(2025-10-28, After Market Close):

- Revenue +4.5% YoY (vs -5.7% in previous quarter and historical rate -10.5%)
- EBITDA +16.7% YoY (vs -14.3% in previous quarter and historical rate -21.3%)
- EBITDA margin 2.9% increased compared to 2.6% same period last year
- Net Debt increased by $15 mln over the past reporting period (4.3% of market cap)
- FCF (LTM) -$0 bln (negative), 10.6% of market cap
- EV/EBITDA multiple is 10.1x compared to historical level (75th percentile) of 9.8x
- EV/Sales multiple is 0.3x

------------------------------------------------

2025-10-29

#reports #VRNS

[Varonis Systems](https://eninvs.com/all.php?name=VRNS) (Software developer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=VRNS&q=2025 q3&id=891032)
(2025-10-28, After Market Close):

- Revenue +9.5% YoY (vs +16.9% in previous quarter and historical rate +20.4%)
- EBITDA margin -11.7% decreased compared to -10.1% same period last year
- Net Debt decreased by $131 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.1% of market cap
- EV/Sales multiple is 9.4x

------------------------------------------------

2025-10-29

#reports #TZOO

[Travelzoo](https://eninvs.com/all.php?name=TZOO) (Advertising Agencies) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=TZOO&q=2025 q3&id=891022)
(2025-10-28, Before Market Open):

- Revenue +10% YoY (vs +14.3% in previous quarter and historical rate +11.7%)
- EBITDA -75% YoY (vs -50.0% in previous quarter and historical rate +28.7%)
- EBITDA margin 4.5% decreased compared to 20.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 5.8% of market cap
- EV/EBITDA multiple is 8.9x compared to historical level (75th percentile) of 9.4x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +1.0% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #TRS

[TriMas](https://eninvs.com/all.php?name=TRS) (Engergy services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192419)
(2025-10-28, Before Market Open):

- Revenue +17.5% YoY (vs +14.1% in previous quarter and historical rate +4.6%)
- EBITDA +50% YoY (vs +32.1% in previous quarter and historical rate +0.6%)
- EBITDA margin 10.0% increased compared to 7.9% same period last year
- Net Debt decreased by $24 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 16.5x compared to historical level (75th percentile) of 15.2x
- EV/Sales multiple is 2x

At the opening of the session the share price went down -6.4% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #THC

[Tenet Healthcare Corporation](https://eninvs.com/all.php?name=THC) (Medical Care Facilities) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192418)
(2025-10-28, Before Market Open):

- Revenue +3.3% YoY (vs +3.3% in previous quarter and historical rate +19.4%)
- EBITDA -14.7% YoY (vs +6.4% in previous quarter and historical rate +70.8%)
- EBITDA margin 20.9% decreased compared to 25.3% same period last year
- Net Debt decreased by $105 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$1.6 bln (negative), 8.6% of market cap
- EV/EBITDA multiple is 4x compared to historical level (75th percentile) of 10.9x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -2.9% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #STX

[Seagate Technology](https://eninvs.com/all.php?name=STX) (Hard disk drives manufacturer) reported for 2025 q3
(2025-10-28, After Market Close):

- Revenue +21.3% YoY (vs +29.5% in previous quarter and historical rate +2.4%)
- EBITDA +64% YoY (vs +61.8% in previous quarter and historical rate +48.0%)
- EBITDA margin 29.1% increased compared to 21.5% same period last year
- Net Debt decreased by $222 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.5 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 19.4x compared to historical level (75th percentile) of 52.9x
- EV/Sales multiple is 5.2x

------------------------------------------------

2025-10-29

#reports #RGEN

[Repligen](https://eninvs.com/all.php?name=RGEN) (Highly innovative biotechnological technologies developer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=RGEN&q=2025 q3&id=891004)
(2025-10-28, Before Market Open):

- Revenue +21.9% YoY (vs +18.2% in previous quarter and historical rate -2.7%)
- EBITDA margin 13.8% increased compared to 0.6% same period last year
- Net Debt decreased by $726 mln over the past reporting period (8.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 162x compared to historical level (75th percentile) of 173.7x
- EV/Sales multiple is 11x

At the opening of the session the share price went up +2.4% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #REGN

[Regeneron Pharmaceuticals](https://eninvs.com/all.php?name=REGN) (Pharmaceutical manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192414)
(2025-10-28, Before Market Open):

- Revenue -18.4% YoY (vs -15.0% in previous quarter and historical rate -10.2%)
- EBITDA -11.9% YoY (vs +0.7% in previous quarter and historical rate -11.1%)
- EBITDA margin 71.3% increased compared to 66.0% same period last year
- Net Debt decreased by $1.2 bln since the start of the year (1.7% of market cap)
- FCF (LTM) +$0.4 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 19.7x
- EV/Sales multiple is 8.1x

At the opening of the session the share price went up +4.6% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #RCL

[Royal Caribbean Cruises](https://eninvs.com/all.php?name=RCL) (Entertainment services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192413)
(2025-10-28, Before Market Open):

- Revenue +5.2% YoY (vs +13.1% in previous quarter and historical rate +43.8%)
- EBITDA +30% YoY (vs +13.3% in previous quarter and historical rate +87.1%)
- EBITDA margin 51.7% increased compared to 41.8% same period last year
- Net Debt increased by $1.6 bln since the start of the year (2.1% of market cap)
- FCF (LTM) +$2.3 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 16.3x compared to historical level (75th percentile) of 19.7x
- EV/Sales multiple is 6x

At the opening of the session the share price went down -7.7% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #RCKY

[Rocky Brands](https://eninvs.com/all.php?name=RCKY) (Footwear and Accessories) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=RCKY&q=2025 q3&id=890999)
(2025-10-28, After Market Close):

- Revenue +7% YoY (vs +8.2% in previous quarter and historical rate -8.7%)
- EBITDA +14.3% YoY (vs +50.0% in previous quarter and historical rate +9.0%)
- EBITDA margin 13.0% increased compared to 12.2% same period last year
- Net Debt increased by $6 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 8.7% of market cap
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 10.2x
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-10-29

#reports #NEO

[NeoGenomics](https://eninvs.com/all.php?name=NEO) (Network of clinical laboratories) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192410)
(2025-10-28, Before Market Open):

- Revenue +11.9% YoY (vs +9.7% in previous quarter and historical rate +12.6%)
- EBITDA margin -5.9% decreased compared to -1.8% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 2.4% of market cap
- EV/Sales multiple is 2.1x

At the opening of the session the share price went up +6.5% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #NBIX

[Neurocrine Biosciences](https://eninvs.com/all.php?name=NBIX) (Therapeutic developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192408)
(2025-10-28, After Market Close):

- Revenue +27.8% YoY (vs +16.6% in previous quarter and historical rate +24.6%)
- EBITDA +28.9% YoY (vs 0.0% in previous quarter and historical rate +40.1%)
- EBITDA margin 30.8% increased compared to 30.5% same period last year
- Net Debt decreased by $275 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0.2 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 17.4x compared to historical level (75th percentile) of 43.8x
- EV/Sales multiple is 4.6x

------------------------------------------------

2025-10-29

#reports #MTLS

[Materialise NV](https://eninvs.com/all.php?name=MTLS) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=6&id=225103)
(2025-10-28, Before Market Open):

- Revenue +1.3% YoY (vs +2.7% in previous quarter and historical rate +8.7%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate -9.1%)
- EBITDA margin 16.7% decreased compared to 16.9% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 12.7x compared to historical level (75th percentile) of 15.2x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +0.5% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #MOD

[Modine Manufacturing Company](https://eninvs.com/all.php?name=MOD) (Auto Parts) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=MOD&q=2025 q3&id=890983)
(2025-10-28, After Market Close):

- Revenue +12.3% YoY (vs +3.2% in previous quarter and historical rate +25.3%)
- EBITDA -2.1% YoY (vs +1.1% in previous quarter and historical rate +33.9%)
- EBITDA margin 12.6% decreased compared to 14.4% same period last year
- Net Debt increased by $95 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 24.7x compared to historical level (75th percentile) of 19.5x
- EV/Sales multiple is 2.7x

------------------------------------------------

2025-10-29

#reports #MDLZ

[Mondelez International](https://eninvs.com/all.php?name=MDLZ) (Food and beverage manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192406)
(2025-10-28, After Market Close):

- Revenue +5.9% YoY (vs +7.7% in previous quarter and historical rate +7.5%)
- EBITDA +27.9% YoY (vs +49.8% in previous quarter and historical rate +20.9%)
- EBITDA margin 15.4% increased compared to 12.8% same period last year
- Net Debt increased by $998 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$4.6 bln (negative), 5.5% of market cap
- EV/EBITDA multiple is 19.2x compared to historical level (75th percentile) of 22.8x
- EV/Sales multiple is 3.3x

------------------------------------------------

2025-10-29

#reports #LSTR

[Landstar System](https://eninvs.com/all.php?name=LSTR) (Logistic services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192404)
(2025-10-28, After Market Close):

- Revenue -0.7% YoY (vs -1.1% in previous quarter and historical rate -13.9%)
- EBITDA -51.3% YoY (vs -18.1% in previous quarter and historical rate -14.5%)
- EBITDA margin 3.2% decreased compared to 6.4% same period last year
- Net Debt decreased by $16 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.6% of market cap
- EV/EBITDA multiple is 18.1x compared to historical level (75th percentile) of 22.8x
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-10-29

#reports #LH

[Laboratory of America](https://eninvs.com/all.php?name=LH) (Medical services provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=LH&q=2025 q3&id=890976)
(2025-10-28, Before Market Open):

- Revenue +8.6% YoY (vs +9.5% in previous quarter and historical rate -2.7%)
- EBITDA +36.5% YoY (vs +25.0% in previous quarter and historical rate -0.4%)
- EBITDA margin 15.9% increased compared to 12.7% same period last year
- Net Debt increased by $33 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.3 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 14.9x compared to historical level (75th percentile) of 19x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went down -3.9% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #KNSA

[Kiniksa Pharmaceuticals](https://eninvs.com/all.php?name=KNSA) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192378)
(2025-10-28, Before Market Open):

- Revenue +61.6% YoY (vs +44.0% in previous quarter and historical rate +69.3%)
- EBITDA margin 54.1% increased compared to -8.0% same period last year
- Net Debt decreased by $44 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 4.8x compared to historical level (75th percentile) of 34.6x
- EV/Sales multiple is 4.2x

At the opening of the session the share price went up +1.9% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #KIDS

[OrthoPediatrics](https://eninvs.com/all.php?name=KIDS) (Medical equipment developer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=KIDS&q=2025 q3&id=890973)
(2025-10-28, After Market Close):

- Revenue +10.9% YoY (vs +15.1% in previous quarter and historical rate +26.1%)
- EBITDA margin -14.8% decreased compared to -10.9% same period last year
- Net Debt increased by $15 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 19.9% of market cap
- EV/Sales multiple is 1.9x

------------------------------------------------

2025-10-29

#reports #IQV

[IQVIA](https://eninvs.com/all.php?name=IQV) (Analytical company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192401)
(2025-10-28, Before Market Open):

- Revenue +5.2% YoY (vs +5.3% in previous quarter and historical rate +3.6%)
- EBITDA +42.4% YoY (vs +24.3% in previous quarter and historical rate +10.2%)
- EBITDA margin 28.8% increased compared to 21.3% same period last year
- Net Debt decreased by $165 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$1.2 bln (negative), 2.8% of market cap
- EV/EBITDA multiple is 14x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 3.4x

At the opening of the session the share price went down -3.3% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #INCY

[Incyte](https://eninvs.com/all.php?name=INCY) (Small molecule drugs developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192400)
(2025-10-28, Before Market Open):

- Revenue +20% YoY (vs +16.5% in previous quarter and historical rate +13.2%)
- EBITDA +190.4% YoY (vs +54700.0% in previous quarter and historical rate +41.3%)
- EBITDA margin 33.2% increased compared to 13.7% same period last year
- Net Debt decreased by $508 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) +$0.6 bln (positive), 3.6% of market cap
- EV/EBITDA multiple is 9.4x compared to historical level (75th percentile) of 56.5x
- EV/Sales multiple is 3.1x

At the opening of the session the share price went down -1.0% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #HURN

[Huron Consulting](https://eninvs.com/all.php?name=HURN) (Financial and operations advisor) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192398)
(2025-10-28, After Market Close):

- Revenue +16.7% YoY (vs +8.1% in previous quarter and historical rate +30.4%)
- EBITDA +37.5% YoY (vs +9.8% in previous quarter and historical rate +54.4%)
- EBITDA margin 17.5% increased compared to 14.8% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 1.4x

------------------------------------------------

2025-10-29

#reports #HUBB

[Hubbell](https://eninvs.com/all.php?name=HUBB) (Electrical and electronic products manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=HUBB&q=2025 q3&id=890964)
(2025-10-28, Before Market Open):

- Revenue +4.1% YoY (vs +2.1% in previous quarter and historical rate +5.7%)
- EBITDA +7.6% YoY (vs +9.7% in previous quarter and historical rate +26.6%)
- EBITDA margin 25.3% increased compared to 24.5% same period last year
- Net Debt decreased by $132 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 18.9x compared to historical level (75th percentile) of 19.5x
- EV/Sales multiple is 4.5x

At the opening of the session the share price went down -2.0% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #HRI

[Herc](https://eninvs.com/all.php?name=HRI) (Rental and Leasing Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192397)
(2025-10-28, Before Market Open):

- Revenue +35.1% YoY (vs +18.2% in previous quarter and historical rate +17.9%)
- EBITDA +46% YoY (vs -17.3% in previous quarter and historical rate +55.5%)
- EBITDA margin 51.2% increased compared to 47.4% same period last year
- Net Debt decreased by $109 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) -$4.8 bln (negative), 116.5% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 8.2x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +2.5% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #GIC

[Global Industrial Company](https://eninvs.com/all.php?name=GIC) (Industrial Distribution) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192395)
(2025-10-28, After Market Close):

- Revenue +3.5% YoY (vs +3.2% in previous quarter and historical rate +5.0%)
- EBITDA +16.7% YoY (vs +25.0% in previous quarter and historical rate -4.5%)
- EBITDA margin 7.9% increased compared to 7.0% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1x

------------------------------------------------

2025-10-29

#reports #FLS

[Flowserve](https://eninvs.com/all.php?name=FLS) (Industrial equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192394)
(2025-10-28, After Market Close):

- Revenue +3.6% YoY (vs +2.7% in previous quarter and historical rate +10.6%)
- EBITDA -3.9% YoY (vs -29.7% in previous quarter and historical rate +39.7%)
- EBITDA margin 8.4% decreased compared to 9.1% same period last year
- Net Debt decreased by $197 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0.2 bln (negative), 3.3% of market cap
- EV/EBITDA multiple is 14.4x compared to historical level (75th percentile) of 14.9x
- EV/Sales multiple is 1.7x

------------------------------------------------

2025-10-29

#reports #FELE

[Franklin Electric Co](https://eninvs.com/all.php?name=FELE) (Electric motor manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=FELE&q=2025 q3&id=890951)
(2025-10-28, Before Market Open):

- Revenue +9.6% YoY (vs +8.1% in previous quarter and historical rate +2.2%)
- EBITDA +14.8% YoY (vs +11.8% in previous quarter and historical rate +4.5%)
- EBITDA margin 17.4% increased compared to 16.6% same period last year
- Net Debt decreased by $74 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0.2 bln (negative), 4.5% of market cap
- EV/EBITDA multiple is 14.3x compared to historical level (75th percentile) of 14.8x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went down -3.1% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #ESI

[Element Solutions](https://eninvs.com/all.php?name=ESI) (Specialty Chemicals) reported for 2025 q3
(2025-10-28, After Market Close):

- Revenue +1.7% YoY (vs +2.0% in previous quarter and historical rate -1.3%)
- EBITDA +5.4% YoY (vs -2.2% in previous quarter and historical rate +26.9%)
- EBITDA margin 18.0% increased compared to 17.4% same period last year
- Net Debt decreased by $64 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.5 bln (positive), 7.0% of market cap
- EV/EBITDA multiple is 17x compared to historical level (75th percentile) of 29.3x
- EV/Sales multiple is 3x

------------------------------------------------

2025-10-29

#reports #ECL

[Ecolab](https://eninvs.com/all.php?name=ECL) ( Infection prevention solutions provider ) reported for 2025 q3
(2025-10-28, Before Market Open):

- Revenue +4.2% YoY (vs +1.0% in previous quarter and historical rate +4.7%)
- EBITDA -22.8% YoY (vs +6.2% in previous quarter and historical rate +14.6%)
- EBITDA margin 23.2% decreased compared to 31.3% same period last year
- Net Debt decreased by $172 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 0.0% of market cap
- EV/EBITDA multiple is 24x compared to historical level (75th percentile) of 24.5x
- EV/Sales multiple is 5.2x

At the opening of the session the share price went down -1.0% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #CWH

[Camping World](https://eninvs.com/all.php?name=CWH) (Camping retailer) reported for 2025 q3
(2025-10-28, After Market Close):

- Revenue +4.7% YoY (vs +9.4% in previous quarter and historical rate -3.1%)
- EBITDA +23.5% YoY (vs +33.9% in previous quarter and historical rate +8.5%)
- EBITDA margin 5.8% increased compared to 4.9% same period last year
- Net Debt decreased by $57 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0.2 bln (negative), 17.4% of market cap
- EV/EBITDA multiple is 15.5x compared to historical level (75th percentile) of 19.6x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-10-29

#reports #CSGP

[CoStar](https://eninvs.com/all.php?name=CSGP) (Real estate information platform) reported for 2025 q3
(2025-10-28, After Market Close):

- Revenue +20.3% YoY (vs +15.2% in previous quarter and historical rate +13.0%)
- EBITDA +83.1% YoY (vs +42.3% in previous quarter and historical rate -3.1%)
- EBITDA margin 19.5% increased compared to 12.8% same period last year
- Net Debt increased by $1.7 bln since the start of the year (5.3% of market cap)
- FCF (LTM) -$1.2 bln (negative), 3.9% of market cap
- EV/EBITDA multiple is 80.5x compared to historical level (75th percentile) of 95.5x
- EV/Sales multiple is 10.1x

------------------------------------------------

2025-10-29

#reports #BE

[Bloom Energy Corporation](https://eninvs.com/all.php?name=BE) (Electrical Equipment and Parts) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192386)
(2025-10-28, After Market Close):

- Revenue +57.3% YoY (vs +19.3% in previous quarter and historical rate +22.1%)
- EBITDA margin 1.5% increased compared to -3.0% same period last year
- Net Debt decreased by $25 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 140.9x compared to historical level (75th percentile) of 79x
- EV/Sales multiple is 11.4x

------------------------------------------------

2025-10-29

#reports #AXTA

[Axalta Coating Systems](https://eninvs.com/all.php?name=AXTA) (Paint and primer manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=AXTA&q=2025 q3&id=890924)
(2025-10-28, Before Market Open):

- Revenue -2.4% YoY (vs -3.4% in previous quarter and historical rate +2.7%)
- EBITDA +19.7% YoY (vs -2.2% in previous quarter and historical rate +13.8%)
- EBITDA margin 24.5% increased compared to 20.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 10.5x
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +3.2% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #ALKS

[Alkermes](https://eninvs.com/all.php?name=ALKS) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192380)
(2025-10-28, Before Market Open):

- Revenue +4.2% YoY (vs -2.0% in previous quarter and historical rate +15.4%)
- EBITDA -69.6% YoY (vs -30.4% in previous quarter and historical rate +70.4%)
- EBITDA margin 1.8% decreased compared to 6.1% same period last year
- Net Debt decreased by $96 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.4 bln (positive), 8.2% of market cap
- EV/EBITDA multiple is 12.7x compared to historical level (75th percentile) of 17.3x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +1.8% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #ABG

[Asbury Automotive Group](https://eninvs.com/all.php?name=ABG) ( Vehicle retailer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=ABG&q=2025 q3&id=890915)
(2025-10-28, Before Market Open):

- Revenue +13.3% YoY (vs +3.0% in previous quarter and historical rate +8.6%)
- EBITDA +4.8% YoY (vs +131.9% in previous quarter and historical rate +25.3%)
- EBITDA margin 5.5% decreased compared to 5.9% same period last year
- Net Debt increased by $1.4 bln since the start of the year (27.3% of market cap)
- FCF (LTM) +$0.8 bln (positive), 14.5% of market cap
- EV/EBITDA multiple is 10.3x compared to historical level (75th percentile) of 10.9x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went up +2.4% vs S&P500 +0.3%

------------------------------------------------

2025-10-29

#reports #AAT

[American Assets Trust](https://eninvs.com/all.php?name=AAT) (REIT — Diversified) reported for 2025 q3
(2025-10-28, After Market Close):

- Revenue -10.6% YoY (vs -2.7% in previous quarter and historical rate +1.9%)
- EBITDA -18.6% YoY (vs -3.3% in previous quarter and historical rate +6.7%)
- EBITDA margin 51.8% decreased compared to 56.9% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 9.9x compared to historical level (75th percentile) of 13.4x
- EV/Sales multiple is 6.3x

------------------------------------------------

2025-10-29

#reports #ENPH
@ renewable-energy

[Enphase Energy](https://eninvs.com/all.php?name=ENPH) (Solar panel manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192392)
(2025-10-28, After Market Close):

- Revenue +7.6% YoY (vs +19.8% in previous quarter and historical rate +3.3%)
- EBITDA +22.9% YoY (vs +159.1% in previous quarter and historical rate +45.8%)
- EBITDA margin 21.0% increased compared to 18.4% same period last year
- Net Debt increased by $53 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.9% of market cap
- EV/EBITDA multiple is 16.8x compared to historical level (75th percentile) of 61x
- EV/Sales multiple is 3x

------------------------------------------------

2025-10-29

#reports #AMT
@ REITs

[American Tower](https://eninvs.com/all.php?name=AMT) (Real estate investment trust) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192381)
(2025-10-28, Before Market Open):

- Revenue +7.7% YoY (vs -9.4% in previous quarter and historical rate -1.7%)
- EBITDA +6.3% YoY (vs -7.5% in previous quarter and historical rate +11.9%)
- EBITDA margin 64.6% decreased compared to 65.5% same period last year
- Net Debt increased by $137 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.6 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 16.2x compared to historical level (75th percentile) of 23.1x
- EV/Sales multiple is 10.1x

At the opening of the session the share price went down -2.0% vs S&P500 +0.3%

Switch to company model in classical logic    *